Neoplasms, Colorectal Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03050814Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004Treatment
NCT03698461Treatment of Colorectal Liver Metastases With Immunotherapy and BevacizumabTreatment
NCT03271255Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Treatment
NCT03511183XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal CancerTreatment